Metraipolis › archive › dc_693ba1913f06

CD22 as a Target for Hematological Malignancies and Autoimmune Diseases — Europe PMC PMID:42353124

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42353124
DOI
10.3390/ijms27125406
License (as archived)
solo-consultazione
Archived
2026-10-19T09:20:04.631Z
SHA-256 of the archived text
401c5c3f505ac07d2beaf0eaa03b85f6611cce638198e625f78eca4d12b80f01
Stable URL of this page
https://metraipolis.com/documento/dc_693ba1913f06

How to cite

CD22 as a Target for Hematological Malignancies and Autoimmune Diseases — Europe PMC PMID:42353124 — Europe PMC (en), https://europepmc.org/article/MED/42353124 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_693ba1913f06 (Metraipolis archive dc_693ba1913f06, sha256 401c5c3f505ac07d2beaf0eaa03b85f6611cce638198e625f78eca4d12b80f01)
BibTeX
@misc{dc693ba1913f06,
  title = {CD22 as a Target for Hematological Malignancies and Autoimmune Diseases — Europe PMC PMID:42353124},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42353124},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_693ba1913f06; sha256 401c5c3f505ac07d2beaf0eaa03b85f6611cce638198e625f78eca4d12b80f01},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42353124. Agents can read the archived copy with the MCP tool read_document.